Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens
The landscape of clinical mycology is constantly changing. New therapies for malignant and autoimmune diseases have led to new risk factors for unusual mycoses. Invasive candidiasis is increasingly caused by non-albicans <i>Candida</i> spp., including <i>C. auris</i>, a multi...
Main Authors: | Daniel Z.P. Friedman, Ilan S. Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/5/3/67 |
Similar Items
-
<i>Candida auris</i>: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
by: Teresa Fasciana, et al.
Published: (2020-11-01) -
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
by: Mahmoud Ghannoum, et al.
Published: (2020-08-01) -
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
by: Amir Arastehfar, et al.
Published: (2020-08-01) -
Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin – case study and brief literature review
by: Marta Barańska, et al.
Published: (2017-02-01) -
Pathogenicity Levels of Colombian Strains of <i>Candida auris</i> and Brazilian Strains of <i>Candida haemulonii</i> Species Complex in Both Murine and <i>Galleria mellonella</i> Experimental Models
by: Julián E. Muñoz, et al.
Published: (2020-07-01)